First reported 12 hours ago -
Updated 12 hours ago -
VIVUS, Inc., a biopharmaceutical company, and Auxilium Pharmaceuticals
, Inc., a fully integrated specialty biopharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for ...
[Published PharmaBiz - 12 hours ago]